RENAISSANCE TECHNOLOGIES LLC
Position in TAK — Takeda Pharmaceutical Co Ltd
CIK 1037389
NEW YORK, NY
Position in TAK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$41,165,040
-$14,193,092 QoQ
Shares Held
2,568,000
-14.1% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#9
of 376 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $2,242,873,379 across 49 Drug Manufacturers - Specialty & Generic names. TAK ranks #9 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,708,739 | $925,846,052 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
2,335,897 | $393,692,080 | |
| 3 | ALKS |
Alkermes plc.
|
6,460,928 | $338,552,627 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
7,347,028 | $106,458,435 | |
| 5 | ZTS |
Zoetis Inc.
|
1,403,300 | $100,841,138 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,478,180 | $68,750,151 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,366,549 | $49,469,073 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
1,733,801 | $43,986,531 |
All Filings in TAK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,165,040 | 2,568,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $55,358,132 | 2,989,100 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $40,819,297 | 2,618,300 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $56,577,744 | 3,864,600 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $51,005,632 | 3,299,200 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $46,954,999 | 3,157,700 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $40,771,256 | 3,079,400 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $45,771,336 | 3,218,800 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $38,235,112 | 2,954,800 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $43,311,798 | 3,118,200 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $47,481,998 | 3,327,400 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $49,982,023 | 3,230,900 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $57,341,500 | 3,650,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $49,001,632 | 2,973,400 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $44,684,640 | 2,864,400 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $36,952,827 | 2,849,100 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $39,709,332 | 2,828,300 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $28,542,624 | 1,993,200 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $23,427,244 | 1,718,800 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $35,330,022 | 2,156,900 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $38,658,510 | 2,297,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $62,715,796 | 3,434,600 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $101,532,340 | 5,578,700 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $102,342,852 | 5,736,707 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $100,546,061 | 5,607,700 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $57,128,412 | 3,763,400 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||